These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 33204726)

  • 1. Is Lutikizumab, an Anti-Interleukin-1
    Cao Z; Li Y; Wang W; Jie S; Hu X; Zhou J; Wu T; Aili D; Long Z; Li Y; Dou P; Wu R
    Biomed Res Int; 2020; 2020():9013283. PubMed ID: 33204726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.
    Fleischmann RM; Bliddal H; Blanco FJ; Schnitzer TJ; Peterfy C; Chen S; Wang L; Feng S; Conaghan PG; Berenbaum F; Pelletier JP; Martel-Pelletier J; Vaeterlein O; Kaeley GS; Liu W; Kosloski MP; Levy G; Zhang L; Medema JK; Levesque MC
    Arthritis Rheumatol; 2019 Jul; 71(7):1056-1069. PubMed ID: 30653843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis.
    Kloppenburg M; Peterfy C; Haugen IK; Kroon F; Chen S; Wang L; Liu W; Levy G; Fleischmann RM; Berenbaum F; van der Heijde D; Bansal P; Wittoek R; Feng S; Fang Y; Saltarelli M; Medema JK; Levesque MC
    Ann Rheum Dis; 2019 Mar; 78(3):413-420. PubMed ID: 30552176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting nerve growth factor, a new option for treatment of osteoarthritis: a network meta-analysis of comparative efficacy and safety with traditional drugs.
    Cao Z; Zhou J; Long Z; Li Y; Sun J; Luo Y; Wang W
    Aging (Albany NY); 2020 Dec; 13(1):1051-1070. PubMed ID: 33293475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies.
    Zeng C; Wei J; Persson MSM; Sarmanova A; Doherty M; Xie D; Wang Y; Li X; Li J; Long H; Lei G; Zhang W
    Br J Sports Med; 2018 May; 52(10):642-650. PubMed ID: 29436380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability, and pharmacodynamics of an anti-interleukin-1α/β dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study.
    Wang SX; Abramson SB; Attur M; Karsdal MA; Preston RA; Lozada CJ; Kosloski MP; Hong F; Jiang P; Saltarelli MJ; Hendrickson BA; Medema JK
    Osteoarthritis Cartilage; 2017 Dec; 25(12):1952-1961. PubMed ID: 28964890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
    Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007744. PubMed ID: 25340915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tramadol for osteoarthritis.
    Toupin April K; Bisaillon J; Welch V; Maxwell LJ; Jüni P; Rutjes AW; Husni ME; Vincent J; El Hindi T; Wells GA; Tugwell P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD005522. PubMed ID: 31132298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
    Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
    Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
    Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroidal anti-inflammatory drugs for acute gout.
    van Durme CM; Wechalekar MD; Buchbinder R; Schlesinger N; van der Heijde D; Landewé RB
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010120. PubMed ID: 25225849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis.
    Myers J; Wielage RC; Han B; Price K; Gahn J; Paget MA; Happich M
    BMC Musculoskelet Disord; 2014 Mar; 15():76. PubMed ID: 24618328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis.
    van Walsem A; Pandhi S; Nixon RM; Guyot P; Karabis A; Moore RA
    Arthritis Res Ther; 2015 Mar; 17(1):66. PubMed ID: 25879879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cells: A New Choice for Nonsurgical Treatment of OA? Results from a Bayesian Network Meta-Analysis.
    Cao Z; Li Y; Gao F; Wu R; Dou P; Wang W; Li Q
    Biomed Res Int; 2021; 2021():6663003. PubMed ID: 33614784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 selective inhibitors in the treatment of osteoarthritis.
    Laine L; White WB; Rostom A; Hochberg M
    Semin Arthritis Rheum; 2008 Dec; 38(3):165-87. PubMed ID: 18177922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.
    Marjoribanks J; Ayeleke RO; Farquhar C; Proctor M
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD001751. PubMed ID: 26224322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.
    Bannuru RR; Schmid CH; Kent DM; Vaysbrot EE; Wong JB; McAlindon TE
    Ann Intern Med; 2015 Jan; 162(1):46-54. PubMed ID: 25560713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative Efficacy and Safety of Anti-Inflammatory Biologic Agents for Osteoarthritis: A Conventional and Network Meta-Analysis.
    Li Y; Mai Y; Cao P; Wen X; Fan T; Wang X; Ruan G; Tang S; Ding C; Zhu Z
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chondroitin for osteoarthritis.
    Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.